BERKELEY, Calif., and VANCOUVER, British Columbia, March 31, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...
• Phase I/IIa clinical study of BriaCell’s lead candidate, Bria-IMT™, with Incyte Corporation’s immune checkpoint ...
Accessibility Tools